(Q42071761)

16 October 2017

title

Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia (English)

1 reference

paroxysmal supraventricular tachycardia

16 October 2017

main subject

0 references

author name string

Cairns CB

series ordinal

1

1 reference

16 October 2017

Niemann JT

series ordinal

2

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 July 1991

1 reference

Annals of Emergency Medicine

16 October 2017

published in

1 reference

16 October 2017

volume

20

1 reference

16 October 2017

issue

7

1 reference

16 October 2017

page(s)

717-721

1 reference

Verapamil: a review of its pharmacological properties and therapeutic use.

16 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980829-7

7 January 2021

Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980829-7

7 January 2021

The use of calcium with verapamil in the management of supraventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980829-7

7 January 2021

Wide complex tachycardia: misdiagnosis and outcome after emergent therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980829-7

7 January 2021

Misdiagnosis of chronic recurrent ventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980829-7

7 January 2021

The relevance of advances in receptor pharmacology to clinical cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980829-7

7 January 2021

Adenosine: cellular mechanisms, pathophysiological roles and clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980829-7

7 January 2021

The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980829-7

7 January 2021

Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980829-7

7 January 2021

Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980829-7

7 January 2021

Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980829-7

7 January 2021

Intravenous adenosine triphosphate during wide QRS complex tachycardia: safety, therapeutic efficacy, and diagnostic utility

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2805%2980829-7

7 January 2021

10.1016/S0196-0644(05)80829-7

Identifiers

DOI

1 reference

16 October 2017

1 reference